11:45 AM EST - Acasti Pharma Inc. : Announced that in order to regain compliance with NASDAQ Minimum Bid Price Rules, it will consolidate the issued and outstanding Class A common shares of the Corporation on the basis of one post-Consolidation Common Share for every 10 pre-Consolidation Common Shares, provided that each fractional Common Share that results from the Consolidation shall be rounded up. Acasti Pharma Inc.
shares V.APO are trading down $0.085 at $0.36.
